Leukocyte telomere length is associated with iron overload in male adults with hereditary hemochromatosis. Issue 10 (23rd October 2020)

• Record Type: Journal Article
• Authors: Martín, Maximilino; Millan, Andrea; Ferraro, Florencia; Tetzlaff, Walter F.; Botta, Eliana; Castro, Marcelo; Boero, Laura; Rey, Jorge; Daruich, Jorge; Frechtel, Gustavo; Meroño, Tomas; Cerrone, Gloria; Brites, Fernando
• Is Part Of: Bioscience reports. Volume 40:Issue 10(2020)
• Publication Date: 2020-10-23
• Subjects: Iron Metabolism -- Iron Overload -- Telomere Lenght; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20201916
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract: Background: Hereditary hemochromatosis (HH) is a primary iron overload (IO) condition. Absolute telomere length (ATL) is a marker of cellular aging and DNA damage associated with chronic diseases and mortality. Aim: To evaluate the relationship between ATL and IO in patients with HH. Methods: Cross-sectional study including 25 patients with HH: 8 with IO and 17 without IO (ferritin < 300 ng/ml) and 25 healthy controls. Inclusion criteria were: age > 18 years, male sex and HH diagnosis. Patients with diabetes or other endocrine and autoimmune diseases were excluded. ATL was measured by real-time PCR. Results: HH patients with IO were older ( P <0.001) and showed higher ferritin concentration ( P <0.001). Patients with HH, disregarding the iron status, showed higher glucose and body mass index (BMI) than controls (both P <0.01). ATL was shorter in patients with IO than controls [with IO: 8 (6–14), without IO: 13 (9–20), and controls: 19 (15–25) kilobase pairs, P <0.01]; with a linear trend within groups ( P for trend <0.01). Differences in ATL remained statistically significant after adjusting by age, BMI and glucose ( P <0.05). Discussion: Patients with IO featured shorter ATL while patients without IO showed only mild alterations vs. controls. Screening for IO is encouraged to prevent iron-associated cellular damage and early telomere attrition.